LGALS3 and type 1 diabetes mellitus: Considering our results that Galectin-3 knockout augmented the proportion of Treg cells in islets and ameliorated insulitis in NOD mice, we sought to assess the potential therapeutic application of Galectin-3 inhibitors for treating T1D.